5 GLP-1 trends to expect in 2026: Expanded uses, oral options, and more Originally developed for Type 2 diabetes, glucagon-like peptide-1 (GLP-1) receptor agonists have transformed the weight-loss medication market
Five percent weight loss would be considered a good response to a dietary intervention, and most who lose weight with diets regain a substantial portion of that weight subsequently
Wellness patients focused on proactive anti-aging and metabolic longevity
Active ingredient: amifampridine Inactive ingredients: calcium stearate, colloidal silicon dioxide, and microcrystalline cellulose
If needed, transfer the reconstituted stock solution to a sterile container for additional dilution to no less than 100 g/mL
Due to the specialized nature of research-grade products, all sales are considered final